Skip to content
Independent analysis of NHS open data
PharmaInsight

Lamzarin 30mg modified-release tablets

0601021M0BQAAAM · Endocrine System
Data updated May 2026
7items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£48

Net ingredient cost · May 2026

NHSBSA PCA

77items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Lamzarin 30mg modified-release tablets: national items dispensed by month

0 9.5 19 Mar 2021 Jul 2022 Dec 2023 Oct 2024 Mar 2025 Aug 2025 May 2026 7 Mar 2021: 1 May 2021: 1 Jan 2022: 3 Feb 2022: 1 Apr 2022: 1 Jul 2022: 1 Aug 2022: 1 Apr 2023: 2 May 2023: 1 Jun 2023: 1 Dec 2023: 2 Jan 2024: 1 Apr 2024: 1 Jul 2024: 7 Sep 2024: 1 Oct 2024: 5 Nov 2024: 9 Dec 2024: 19 Jan 2025: 19 Feb 2025: 12 Mar 2025: 12 Apr 2025: 13 May 2025: 14 Jun 2025: 13 Jul 2025: 11 Aug 2025: 12 Sep 2025: 9 Oct 2025: 2 Nov 2025: 3 Dec 2025: 4 Jan 2026: 1 Feb 2026: 5 Mar 2026: 5 Apr 2026: 5 May 2026: 7

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Gliclazide. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).